0001562180-18-002856.txt : 20180605 0001562180-18-002856.hdr.sgml : 20180605 20180605142301 ACCESSION NUMBER: 0001562180-18-002856 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180605 FILED AS OF DATE: 20180605 DATE AS OF CHANGE: 20180605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moses Jennifer K. CENTRAL INDEX KEY: 0001706667 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38096 FILM NUMBER: 18880743 MAIL ADDRESS: STREET 1: 79 TW ALEXANDER DRIVE STREET 2: 4501 RESEARCH COMMONS, SUITE 100 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: G1 Therapeutics, Inc. CENTRAL INDEX KEY: 0001560241 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263648180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 79 T.W. ALEXANDER DRIVE STREET 2: 4501 RESEARCH COMMONS, SUITE 100 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-213-9835 MAIL ADDRESS: STREET 1: P. O. BOX # 110341 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: G-Zero Therapeutics, Inc. DATE OF NAME CHANGE: 20121012 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-06-05 false 0001560241 G1 Therapeutics, Inc. GTHX 0001706667 Moses Jennifer K. C/O G1 THERAPEUTICS, 79 TW ALEXANDER DR. 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 false true false false VP of Finance & Admin Common Stock 2018-06-05 4 M false 750.00 0.39 A 750.00 D Common Stock 2018-06-05 4 S false 750.00 38.77 D 0.00 D Stock Options (Right to Buy) 0.39 2018-06-05 4 M false 250.00 0.00 D 2023-12-05 Common Stock 250.00 0.00 D Stock Options (Right to Buy) 0.39 2018-06-05 4 M false 500.00 0.00 D 2024-07-11 Common Stock 500.00 6166.00 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. All shares underlying this option have vested. /s/ Peter N. Cunningham, attorney-in-fact 2018-06-05